Proteomics International Laboratories (ASX:PIQ) managing director, Richard Lipscombe, joined Proactive's CEO Sessions in Melbourne on Tuesday, 11th April and Sydney on Wednesday, 12th April.
Proteomics is a revenue generating company holding the unique position as having the world's first diagnostic test at a commercialisation stage.
The company has proven technology with patents granted, with an Asian focus and global reach.